Teledyne Technologies has crossed from a FLIR-integration and deleveraging story into an organic compounder that still has unused acquisition capacity. Infrared detectors and systems for space, airborne and marine unmanned platforms, plus counter-unmanned work, are finally doing the economic work the imaging franchise was assembled to do. Digital Imaging led the second-quarter acceleration, and incremental sales from recent deals were only a sliver of the print. The company is no longer waiting on mix or cost takeout to prove the scale event from the FLIR purchase. The open question is whether this growth rate is a catch-up quarter or a new run-rate.
The print was the strongest quarter in company history on orders, sales and operating profit, and management raised the full-year earnings outlook for a second time. Almost all of the sales gain was organic. That is the friendlier read of the period. The less friendly read is that Digital Imaging margin expansion got help from tariff refunds, and that the August agreement to buy Varex Imaging for about $1.1 billion reopens integration risk just as leverage hit a six-year low. Cash that could have retired more notes or funded buybacks is now spoken for. Serial acquisition is the historical earnings engine, so the market has to decide whether Varex is the next FLIR-quality platform or a stretch into a more competitive medical-components market.
Sales rose to $1.66 billion. Non-GAAP earnings per share rose to $6.28. Funded backlog finished near $5.0 billion, and orders have now exceeded sales for eleven straight quarters. Free cash flow covered a $450 million note repayment and still left net debt near $1.69 billion. The next several quarters resolve whether defense and unmanned demand stay this firm after Varex cash leaves the balance sheet, and whether commercial inspection and healthcare keep the mid-single-digit recovery management now assumes.